vanoxerine (GBR 12909) / Laguna Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
vanoxerine (GBR 12909) / Laguna Pharma
RESTORE SR, NCT02454283 / 2015-001529-18: Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm

Terminated
3
41
US, Europe, RoW
Vanoxerine HCl, Placebo
Laguna Pharmaceuticals, Inc.
Atrial Fibrillation or Flutter
11/15
11/15

Download Options